logo

For the Inventor, By the Inventor

Budapest, Hungary

Éva Csikós

This inventor holds 4 USPTO granted patents. Top assignee: Sanofi-Synthelabo. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Éva Csikós. Retrieved from https://idiyas.com/inventor/andeacuteva-csikandoacutes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

Average Co-Inventor Count = 12.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal4 out of 152 
 
Sanofi-Synthelabo
 patents

Years Active: 2003

Loading Chart...
4 patents (USPTO):Explore Patents
1. 6600039 - PROCESS FOR THE PREPARATION OF N-(1,1-DIMETHYLETHYL)-4-[[5′-ETHOXY-4-CIS[2-(4-MORPHOLINO)ETHOXY]-2′-OXOSPIRO[CYCLOHEXAN-1,3′[H]INDOL]1′(2′-H)-YL]-SULFONYL]-3-METHOXYBENZAMIDE AND ITS SALTS (2003-07-29),
2. 6573386 - Process for the preparation of spiro[(4-cyclohexanone)-[3H]indol]-2′[1′H]-one derivatives (2003-06-03),
3. 6548702 - Method for the preparation of 2-methoxy-4-(N-t-butylamino-carbonyl)-benzenesulfonyl chloride (2003-04-15),
4. 6541643 - Process for the preparation of spiro[cis-4-(&bgr;-hydroxyethyloxy)cyclohexane-[3h]indol]-2′[1′H]one derivatives (2003-04-01),

Title: Innovations and Contributions of Éva Csikós

Introduction

Éva Csikós is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds and processes. With a total of 4 patents to his name, his work has garnered attention in both academic and industrial circles.

Latest Patents

His latest patents include a process for the preparation of N-(1,1-dimethylethyl)-4-[[5'-ethoxy-4-cis[2-(4-morpholino)ethoxy]]-2'-oxospiro[cyclohexan-1,3'H]indol]1'(2'-H)-yl]-sulfonyl-3-methoxybenzamide and its salts. This invention relates to a method of synthesizing a compound by reacting specific chemical formulas in dimethyl sulfoxide at controlled temperatures. Another significant patent involves the preparation of spiro[(4-cyclohexanone)-[3H]indol]-2'[1'H]-one derivatives, characterized by a series of chemical reactions that introduce protective groups and cyclize the resulting compounds.

Career Highlights

Éva Csikós is currently associated with Sanofi-Synthelabo, a leading global healthcare company. His work at Sanofi-Synthelabo has allowed him to collaborate on various innovative projects that aim to enhance pharmaceutical development.

Collaborations

Some of his notable coworkers include Csaba Gönczi and István Hermecz. Their collaborative efforts have contributed to the advancement of research and development in their respective fields.

Conclusion

Éva Csikós stands out as a prominent inventor whose work has significantly impacted the field of chemistry. His innovative patents and collaborations reflect his dedication to advancing scientific knowledge and practical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…